Medhelp Care Aktiebolag (publ) (MEDHLP.ST)
SEK 3.06
(0.0%)
SEK 3.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10 Million SEK | 404.9% |
| 2022 | 1.98 Million SEK | -76.62% |
| 2021 | 8.47 Million SEK | -45.58% |
| 2020 | 14.94 Million SEK | 153.74% |
| 2019 | 6.28 Million SEK | 7.35% |
| 2018 | 5.71 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 5.77 Million SEK | 144.62% |
| 2024 Q2 | 2.36 Million SEK | -5.83% |
| 2024 Q1 | 2.5 Million SEK | 426.3% |
| 2023 Q3 | 3.85 Million SEK | 64.15% |
| 2023 FY | - SEK | 404.9% |
| 2023 Q4 | 2.19 Million SEK | -42.98% |
| 2023 Q2 | 2.34 Million SEK | -5.71% |
| 2023 Q1 | 2.48 Million SEK | 60.1% |
| 2022 Q3 | 3.45 Million SEK | 432.69% |
| 2022 Q2 | -1.03 Million SEK | 43.89% |
| 2022 Q1 | -1.84 Million SEK | 13.04% |
| 2022 FY | - SEK | -76.62% |
| 2022 Q4 | 1.55 Million SEK | -54.96% |
| 2021 FY | - SEK | -45.58% |
| 2021 Q4 | -2.12 Million SEK | -146.32% |
| 2021 Q3 | 4.58 Million SEK | 43.6% |
| 2021 Q2 | 3.19 Million SEK | 59.83% |
| 2021 Q1 | 1.99 Million SEK | -8.89% |
| 2020 FY | - SEK | 153.74% |
| 2020 Q4 | 2.19 Million SEK | 0.0% |
| 2020 Q3 | 2.19 Million SEK | -58.44% |
| 2020 Q2 | 5.27 Million SEK | 0.0% |
| 2020 Q1 | 5.27 Million SEK | 0.0% |
| 2019 FY | - SEK | 7.35% |
| 2018 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aino Health AB (publ) | -7.52 Million SEK | 232.846% |
| Bonzun AB (publ) | -28.58 Million SEK | 134.991% |
| Kontigo Care AB (publ) | 1.67 Million SEK | -496.067% |
| RaySearch Laboratories AB (publ) | 405.93 Million SEK | 97.536% |
| Surgical Science Sweden AB (publ) | 246.9 Million SEK | 95.949% |